US Stock MarketDetailed Quotes
AEON AEON Biopharma
- 1.010
- +0.020+2.02%
Close Aug 14 16:00 ET
- 1.010
- 0.0000.00%
Post 20:02 ET
39.92MMarket Cap-97P/E (TTM)
1.020High0.980Low63.43KVolume1.000Open0.990Pre Close63.44KTurnover0.40%Turnover RatioLossP/E (Static)39.52MShares17.17052wk High-1.43P/B16.23MFloat Cap0.80052wk Low--Dividend TTM16.07MShs Float17.170Historical High--Div YieldTTM4.04%Amplitude0.800Historical Low1.000Avg Price1Lot Size
AEON Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.99%2.52M | |
| Operating revenue | --0 | --0 | ---- | --0 | --0 | --0 | --0 | --0 | --0 | -24.99%2.52M |
| Cost of revenue | 0 | |||||||||
| Gross profit | -24.97%2.52M | |||||||||
| Operating expense | -44.46%7.76M | -20.43%10.38M | 13.97M | 13.05M | 31.31%48.43M | 15.03M | 9.91M | 95.08%36.88M | -63.45%18.91M | |
| Selling and administrative expenses | -32.85%3.32M | 21.04%4.65M | ---- | --4.95M | --3.84M | 22.61%13.68M | --5.5M | --2.44M | -3.75%11.15M | -74.83%11.59M |
| Research and development costs | -50.81%4.44M | -37.73%5.73M | ---- | --9.03M | --9.21M | 35.08%34.75M | --9.53M | --7.48M | 251.52%25.73M | 52.04%7.32M |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Operating profit | 44.46%-7.76M | 20.43%-10.38M | -13.97M | -13.05M | -31.31%-48.43M | -15.03M | -9.91M | -125.05%-36.88M | 66.12%-16.39M | |
| Net non-operating interest income expense | 99.78%-15K | |||||||||
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.80%15K |
| Other net income (expense) | 12,306.82%171.87M | -2,243.50%-107.64M | -1.41M | -4.59M | 78.00%-4.13M | -19.53M | -525K | -13.60%-18.76M | -108.22%-16.51M | |
| Gain on sale of security | --8.81M | ---43.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.70%346K |
| Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -102.08%-140K |
| Special income (charges) | --161.23M | ---63.77M | ---- | --0 | --0 | --0 | --0 | --0 | -160.91%-28.97M | -104.37%-11.1M |
| -Less：Restructuring and merger&acquisition | ---161.23M | --63.77M | ---- | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 160.91%28.97M | --11.1M |
| -Gain on sale of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Other non- operating income (expenses) | 229.90%1.83M | 98.95%-48K | ---- | ---1.41M | ---4.59M | -140.42%-4.13M | ---19.53M | ---525K | 281.87%10.21M | 47.78%-5.61M |
| Income before tax | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | -122.59%-32.91M | |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net income | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | -120.53%-32.91M | |
| Net income continuous Operations | 1,167.12%164.11M | -569.07%-118.02M | ---- | ---15.38M | ---17.64M | 5.54%-52.56M | ---34.56M | ---10.44M | -69.04%-55.64M | -120.53%-32.91M |
| Minority interest income | 0 | |||||||||
| Net income attributable to the parent company | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -69.04%-55.64M | -119.03%-32.91M | |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | -5.47M | |||||||||
| Net income attributable to common stockholders | 1,167.12%164.11M | -569.07%-118.02M | -15.38M | -17.64M | 5.54%-52.56M | -34.56M | -10.44M | -102.73%-55.64M | -115.87%-27.44M | |
| Basic earnings per share | 852.70%4.22 | -295.30%-3.17 | -0.5606 | -0.8019 | 5.54%-2.3893 | -1.5713 | -0.4745 | -36.72%-2.5294 | -115.83%-1.85 | |
| Diluted earnings per share | 852.70%4.22 | -295.30%-3.17 | -0.5606 | -0.8019 | 5.54%-2.3893 | -1.5713 | -0.4745 | -36.72%-2.5294 | -115.83%-1.85 | |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | Unqualified Opinion | Unqualified Opinion with Explanatory Notes |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg